Diphen­yl(1,1,3,3‐tetra­methyl‐2,3‐dihydro‐1H‐isoindol‐2‐yl)phosphine oxide

By  

Acta Crystallographica Section E, Vol. 62, Iss. 6, 2006-06 ,pp. : o2329-o2330

John Wiley & Sons Inc

Access to resources Recommend Favorite

4‐[4‐(1,3‐Dioxo‐2,3‐di­hydro‐1H‐isoindol‐2‐yl)­butoxy]­phthalo­nitrile

By  

Acta Crystallographica Section E, Vol. 61, Iss. 5, 2005-05 ,pp. : o1214-o1215

John Wiley & Sons Inc

Access to resources Recommend Favorite

3‐[2‐(1,3‐Dioxo‐2,3‐dihydro‐1H‐isoindol‐2‐yl)ethyl] 5‐methyl 2,6‐dimethyl‐4‐(3‐nitrophenyl)‐1,4‐dihydropyridine‐3,5‐dicarboxylate

By  

Acta Crystallographica Section E, Vol. 63, Iss. 7, 2007-07 ,pp. : o3176-o3176

John Wiley & Sons Inc

Access to resources Recommend Favorite

{3‐[2‐Methoxy‐5‐(1‐methyl‐1‐phenyl­ethyl)­phenyl]‐2,5‐di­phenyl‐1,2,3,4‐tetra­hydro‐4‐isoxazol‐4‐yl}(2‐thienyl)­methano­ne

By  

Acta Crystallographica Section E, Vol. 60, Iss. 12, 2004-12 ,pp. : o2503-o2505

John Wiley & Sons Inc

Access to resources Recommend Favorite

1,5‐Di­methyl‐4‐[(4‐nitro­benzyl­idene)­amino]‐2‐phenyl‐2,3‐di­hydro‐1H‐pyrazol‐3‐one

By  

Acta Crystallographica Section E, Vol. 60, Iss. 12, 2004-12 ,pp. : o2199-o2200

John Wiley & Sons Inc

Access to resources Recommend Favorite